Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin

Journal of Pharmaceutical Sciences
C DamgéPatrick Couvreur

Abstract

Poly(alkyl cyanoacrylate) nanocapsules have been successfully used for oral administration of insulin in diabetic rats. This work reports a suitable formulation for insulin-loaded nanospheres composed of full polymeric structures formed by polymerization of isobutyl cyanoacrylate (IBCA) in an acidic medium, insulin (15 U/mL) being added to the polymerization medium 60 min after the onset of polymerization. These nanospheres (MW 364) displayed a mean size of 145 nm and an association rate of 1 U of insulin/mg of polymer. They protected insulin from the degradation by proteolytic enzymes in vitro, especially when they were dispersed in an oily medium (Miglyol 812) containing surfactive agents (Poloxamer 188 and deoxycholic acid). When dispersed in the same medium, insulin-loaded nanospheres (100 U/kg of body weight), administered perorally in streptozotocin-induced diabetic rats, provoked a 50% decrease of fasted glycemia from the second hour up to 10-13 days. This effect was shorter (2 days) or absent when nanospheres were dispersed in water with surfactive agents or not. Using 14C-labeled nanospheres loaded with [125I]insulin, it was found that nanospheres increased the uptake of [125I]insulin or its metabolites in the gastroin...Continue Reading

References

Mar 1, 1978·Diabetes·S HaraiT Matsuzawa
Nov 1, 1992·Chemical & Pharmaceutical Bulletin·Y WatanabeM Matsumoto
May 1, 1992·Diabetic Medicine : a Journal of the British Diabetic Association·K DrejerN Mygind
Oct 1, 1989·Journal of Pharmaceutical Sciences·G C Chiou, C Y Chuang
May 1, 1987·Journal of Pharmaceutical Sciences·J P LongeneckerE J Dubovi
Apr 1, 1987·Biochemical Pharmacology·E ZivM Kidron
Oct 1, 1986·Journal of Pharmaceutical Sciences·P MaincentJ P Devissaguet
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·G S GordonM C Carey
Oct 1, 1968·Diabetes·C W Crane, G R Luntz
May 1, 1980·The Journal of Pharmacy and Pharmacology·K IchikawaH Kawata
May 1, 1981·The Journal of Pharmacy and Pharmacology·T NishihataL Caldwell
Mar 1, 1984·Biomaterials·V LenaertsP Speiser
May 1, 1981·British Journal of Pharmacology·H Bar-OnE Ziv
Aug 24, 1981·Life Sciences·E ZivH Bar-On
Nov 1, 1994·The Journal of Pharmacy and Pharmacology·H SasakiJ Nakamura
Jan 1, 1993·Journal of Drug Targeting·D SchererJ Kreuter
Nov 1, 1995·Journal of Pharmaceutical Sciences·D J PillionC R Kensil
Jan 1, 1985·Pharmaceutical Research·L VansnickM Roland

❮ Previous
Next ❯

Citations

Jun 20, 2007·Pharmaceutical Research·B SarmentoD Ferreira
Mar 30, 2004·Biomaterials·Cariline O Sullivan, Colin Birkinshaw
Mar 17, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alexander H KraulandAndreas Bernkop-Schnürch
Apr 16, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·P ArbósJ M Irache
Apr 23, 2003·Advanced Drug Delivery Reviews·Christine VauthierPatrick Couvreur
Mar 17, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Fabienne CournarieChristine Vauthier
Apr 29, 2000·Pharmaceutical Science & Technology Today·G M Barratt
Oct 24, 2002·Acta Physiologica Scandinavica·S WheelerJ D Morrison
May 18, 2004·Human Gene Therapy·Shwu-Fen ChangJiahorng Liaw
Mar 12, 2005·AAPS PharmSciTech·Hannele EerikäinenEsko I Kauppinen
Dec 16, 2005·AAPS PharmSciTech·Deepti JainDipak K Majumdar
Jan 5, 2002·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·A Yamamoto
Jul 10, 2008·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Camile B WoitiskiFrancisco Veiga
Nov 26, 2008·Nanomedicine·Maria de la FuenteMaria Jose Alonso
Feb 28, 2013·Therapeutic Delivery·Noriyasu KameiMariko Takeda-Morishita
Jul 27, 2012·Therapeutic Delivery·Colin Thompson, Chidinma Ibie
Jan 25, 2013·Therapeutic Delivery·Catarina Pinto ReisCatarina Rosado
Jul 2, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Eric M PridgenOmid C Farokhzad
Aug 1, 2011·Drug Delivery and Translational Research·Pedro FonteBruno Sarmento
Feb 16, 2016·Journal of Microencapsulation·Soon Chuan WongKian Sek Tee
Dec 22, 2007·Expert Opinion on Drug Delivery·Christiane DamgéPhilippe Maincent
May 11, 2004·Drug Development and Industrial Pharmacy·Kun Cheng, Lee-Yong Lim
Jun 2, 2009·Expert Opinion on Drug Delivery·Sania MansouriMaryam Tabrizian
Apr 23, 2008·Expert Opinion on Drug Delivery·V Ramesh BabuTejraj M Aminabhavi
Nov 13, 2003·Drug Delivery·Jaleh VarshosazAbdolhossein Rouholamini Najafabadi
Mar 31, 2015·Expert Opinion on Drug Delivery·Eric M PridgenOmid C Farokhzad
Jul 7, 2007·Journal of Drug Targeting·Akhlesh K JainPrakash V Diwan
Jul 20, 2006·Journal of Pharmaceutical Sciences·S Narasimha MurthyArindam Sen
Dec 4, 2012·Colloids and Surfaces. B, Biointerfaces·Parvin Zakeri-MilaniHadi Valizadeh
Sep 4, 2012·International Journal of Pharmaceutics·Nathalie ReixSéverine Sigrist
Jan 4, 2012·Advanced Drug Delivery Reviews·Laura M EnsignJustin Hanes
Jan 27, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Anja GrafSarah M Hook
Jan 10, 2009·Advanced Drug Delivery Reviews·Samuel K LaiJustin Hanes
Dec 20, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Noriyasu KameiKozo Takayama
Mar 11, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Anja GrafThomas Rades
Feb 9, 2007·International Journal of Pharmaceutics·Vaithilingam Selvaraj, Muthukaruppan Alagar
Aug 25, 2004·The Journal of Pharmacy and Pharmacology·Chun-Lei Li, Ying-Jie Deng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Pharmacy and Pharmacology
C DamgéM Pinget
Journal of Controlled Release : Official Journal of the Controlled Release Society
G P CarinoE Mathiowitz
© 2021 Meta ULC. All rights reserved